Previous 10 | Next 10 |
MENLO PARK, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced preliminary unaudited financial resul...
Sight Sciences (NASDAQ:SGHT) has added ~1.2% in the pre-market after announcing that the FDA has issued 510(k) clearance for the company’s TearCare System for meibomian gland dysfunction (MGD), the main reason for dry eye disease (DED). The FDA has greenlighted TearCare Syste...
MENLO PARK, Calif., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced U.S. Food and Drug Administra...
Point Roberts, WA and Delta, BC - November 19, 2021 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Life Sciences and Mining. Today's stocks have been added to our lists of free stock...
MENLO PARK, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced plans to participate in the ...
MENLO PARK, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced publication in Clinical ...
Sight Sciences Inc. (SGHT) Q3 2021 Results Conference Call November 10, 2021 04:30 PM ET Company Participants Philip Taylor - Gilmartin Group Paul Badawi - Co-Founder, CEO Jesse Selnick - CFO Shawn O'Neil - Chief Commercial Officer Conference Call Participants Cecilia Furlong - Morgan Stanley...
Image source: The Motley Fool. Sight Sciences, Inc. (NASDAQ: SGHT) Q3 2021 Earnings Call Nov 10, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Sight Sciences, Inc. (SGHT) Q3 2021 Earnings Call Transcript
Sight Sciences (NASDAQ:SGHT): Q3 GAAP EPS of -$0.43 misses by $0.07. Revenue of $13.1M (+51.4% Y/Y) beats by $1.03M. Press Release For further details see: Sight Sciences EPS misses by $0.07, beats on revenue
MENLO PARK, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today reported financial results for the quarter ende...
News, Short Squeeze, Breakout and More Instantly...
2024-06-17 00:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
MENLO PARK, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of ...
MENLO PARK, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform car...